PKG inhibitor peptide TFA

CAS No.

PKG inhibitor peptide TFA ( )

Catalog No. M30222 CAS No.

PKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    PKG inhibitor peptide TFA
  • Note
    Research use only, not for human use.
  • Brief Description
    PKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.
  • Description
    PKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.(In Vitro):PKG inhibitor peptide TFA binds to cGMP-dependent protein kinase directly with a Ki of 86 μM.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Ki: 86 μM (PKG)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    --
  • Formula Weight
    1057.1
  • Molecular Formula
    C40H75F3N18O12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Bhatnagar D, et al. Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates. Biochemistry. 1988 Mar 22;27(6):1988-94.
molnova catalog
related products
  • Ganoderic acid N

    23-Dihydroganoderic Acid N has anticancer effects.

  • 6-Aminocaproic acid

    6-Aminocaproic acid is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.

  • Ivermectin B1a

    Ivermectin B1a is the major (80%) component of commercially available ivermectin and a derivative of Avermectin B1a.